Latest / Stock Movers / eBay Rises, Moderna Trades Higher, Vita Coco Falls
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News.
- 0:08Speaker 2: The Stock Movers report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: I'm Carol Messer, Long items Static. Let's get to some
- 0:19Speaker 3: stocks on the move as we try to ponder some
- 0:22Speaker 3: of the bigger meanings of financial markets with us. It
- 0:26Speaker 3: is Bloomberg News Equities reporter Avalon Pronounce.
- 0:28Speaker 2: She's back with us.
- 0:30Speaker 4: Yeah.
- 0:31Speaker 3: Some stocks in the move today. Yeah.
- 0:33Speaker 5: Let's start off with eBay.
- 0:34Speaker 4: Tick her.
- 0:35Speaker 5: eBay. The shares are up about six point one percent
- 0:38Speaker 5: after market after the online marketplace reported fourth quarter earning
- 0:42Speaker 5: sat basically seated expectations across the board, and that's a
- 0:46Speaker 5: welcome sign for investors at eBay's focus on luxury items
- 0:50Speaker 5: and also refurbish goods is continuing to help the company
- 0:53Speaker 5: stand out among a pretty large group of e commerce
- 0:58Speaker 5: companies right now in the market. Also wanted to draw
- 1:00Speaker 5: attention to the fact that it plans to buy Deepop
- 1:03Speaker 5: from et C, which is a pretty big deal since
- 1:05Speaker 5: I can say at least deep Hop is incredibly popular
- 1:08Speaker 5: among gen Z and younger shoppers.
- 1:10Speaker 1: Said that because as a not gen Z person, I
- 1:14Speaker 1: don't know what it is, but the New York Times
- 1:18Speaker 1: calls it a secondhand clothing up popular with gen.
- 1:21Speaker 5: Zh, a very good definition in my opinion. I bought
- 1:25Speaker 5: a leather jacket from there in the past, but it's
- 1:27Speaker 5: basically eBay for gen Z.
- 1:31Speaker 4: And sold it to eBay, yes.
- 1:33Speaker 5: For roughly one point two billion dollars.
- 1:35Speaker 3: It's a bunch of these types of sites. Yeah, yes, right,
- 1:38Speaker 3: I'm trying to think of the other ones. Yeah, okay,
- 1:40Speaker 3: So got Cary thread up. So many options, right, there's
- 1:42Speaker 3: so many different options. So is that one like investors?
- 1:45Speaker 3: I mean, they also gave a good outlook, right their
- 1:47Speaker 3: first quarter net revenue, so they're kind of on the
- 1:49Speaker 3: move here, Yes, that's quite it fascinating like they're kind
- 1:52Speaker 3: of thinking about maybe their next era.
- 1:55Speaker 1: Yeah.
- 1:55Speaker 5: And Etsy is also jumping along with that news. It's
- 1:58Speaker 5: up about fifteen percent after market after this deal. So
- 2:01Speaker 5: across the board for those who are interested in secondhand
- 2:04Speaker 5: fashion or also just goods like Etsy, it's kind of
- 2:09Speaker 5: up across the board.
- 2:10Speaker 1: Etsy bought deepop in twenty twenty one for one point
- 2:13Speaker 1: six billion dollars. Now they're selling it for about one
- 2:16Speaker 1: point two billion dollars.
- 2:17Speaker 4: Wow. That's a little bit of a haircut.
- 2:19Speaker 3: Okay, okay, all right, So watching that one, let's go
- 2:22Speaker 3: to Maderna.
- 2:23Speaker 5: Yes, Maderna, I'm a healthcare reporter. So it ended up
- 2:26Speaker 5: about six percent after the FDA agreed to review its
- 2:30Speaker 5: flu shot and a kind of stunning reversal, especially since
- 2:32Speaker 5: the flu shot is made with mRNA technology, which has
- 2:36Speaker 5: been kind of politicized lately in the current environment. But
- 2:39Speaker 5: that being said, I thought it was really interesting that
- 2:42Speaker 5: one analyst mentioned that there could be some upside for
- 2:44Speaker 5: other companies as well, like Unicore, who has been quite
- 2:48Speaker 5: popular given their Huntington's experimental therapy, which anyone who knows
- 2:53Speaker 5: about that rare disease, it is fatal in all cases
- 2:56Speaker 5: and there's no treatments for it. So there's some investors
- 2:59Speaker 5: who are really hopeful that Unicure also their shares went
- 3:02Speaker 5: up about eight percent on the news that maybe this
- 3:04Speaker 5: could be a sign that the FDA will also reverse
- 3:06Speaker 5: his decision in their case as well.
- 3:09Speaker 3: And those tickers for in case you care, Maderna of
- 3:11Speaker 3: course at mr NA and that stuck is up about
- 3:13Speaker 3: sixty percent year to date, and then Unicure qur E.
- 3:18Speaker 1: Yeah, like you said, mixed messages though from HHS in
- 3:23Speaker 1: the FDA in recent months about mRNA and we've seen
- 3:28Speaker 1: mRNA vaccines and we've seen shares of Moderna really volatile
- 3:32Speaker 1: on the kind.
- 3:33Speaker 4: Of confusion that investors are interpreting.
- 3:36Speaker 5: Yeah, they've taken a beating, especially amongst some critics within
- 3:39Speaker 5: the FDA who are not necessarily as for vaccines when
- 3:44Speaker 5: you look at the AHHSS. That being said, the FDA
- 3:47Speaker 5: has had a lot of shakeups in terms of leadership,
- 3:50Speaker 5: and so we will see as well, like what which
- 3:53Speaker 5: way they're going to be turning still unclear.
- 3:55Speaker 3: A little perspective. I mean, I'm going to go where
- 3:57Speaker 3: it's obvious, but let's just go there. But back in
- 3:59Speaker 3: twenty twenty one, Maderna was a four hundred and eighty
- 4:03Speaker 3: four dollars a share stock. Today it closed just under
- 4:06Speaker 3: forty seven dollars, so we know how much it has
- 4:09Speaker 3: pulled back. It's bounced back already this year, but a
- 4:12Speaker 3: long long way to go.
- 4:14Speaker 5: Can we talk about coconut water, Yes, yes, Vita Coco
- 4:18Speaker 5: taker Coco is also kind of continuing along that theme
- 4:22Speaker 5: of consumer sentiment. Those shares slit about eleven percent at
- 4:25Speaker 5: the close, which actually moved the stock negative. For the year.
- 4:29Speaker 5: Before today, Vita Coco was up about seven percent. The
- 4:32Speaker 5: fall comes after some kind of mixed guidance to a
- 4:35Speaker 5: certain degree, despite having a pretty good quarter. Analysts called
- 4:39Speaker 5: out like the increased promotions that they're planning to do
- 4:41Speaker 5: in the US, some potential timing shifts, and also some
- 4:44Speaker 5: inventory adjustments as potential mixed signals about where exactly the
- 4:49Speaker 5: consumer leads. But Evercore analysts still remain fairly bullished. They
- 4:53Speaker 5: set up in a note today that despite the complexity
- 4:56Speaker 5: in twenty twenty five, Vita Coco should have potentially the
- 5:00Speaker 5: US gross story and beverages for this coming year as
- 5:02Speaker 5: health and wellness continues to be a great trend of
- 5:05Speaker 5: the US.
- 5:05Speaker 3: Not a coconut water kind of getting.
- 5:06Speaker 4: Oh I love coconute.
- 5:08Speaker 1: Yeah, but I'll be honest, I'm too cheap to buy it,
- 5:10Speaker 1: so I just like don't buy it.
- 5:12Speaker 5: When I was yeah, I mean we have it upstairs.
- 5:15Speaker 4: No, yes, what?
- 5:17Speaker 5: Yeah?
- 5:18Speaker 1: Yeah, I think I think that's coconut soda.
- 5:23Speaker 4: I don't think so we have coconut water. I'm pretty sure.
- 5:26Speaker 4: All right, I gotta go.
- 5:29Speaker 2: This stock movers report from Bloomberg Radio check Back with
- 5:33Speaker 2: us throughout the day for the latest roundup of companies
- 5:36Speaker 2: making news on Wall Street, and for the latest market
- 5:39Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 5:43Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 5:47Speaker 2: the Bloomberg Business app.